Avience Biomedicals Limited (NSE:AVIENCE)

India · Delayed Price · Currency is INR

280.35

-5.50 (-1.92%)

At close: Jul 14, 2026

Market Cap	1.54B
Revenue (ttm)	452.36M +3,892.4%
Net Income	72.91M +15,186.9%
EPS	19.22 +152.5%
Shares Out	5.49M
PE Ratio	14.59
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,600
Open	285.00
Previous Close	285.85
Day's Range	278.00 - 296.00
52-Week Range	208.00 - 414.95
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Avience Biomedicals

Avience Biomedicals Limited manufactures and sells Vitro-Diagnostic products and medical devices in India. The company's products include reagents and consumables, such as biochemistry reagents, hematology reagents, immunoassay reagents, electrolyte reagents, and cuvettes, pipette tips, test tubes, microplates, and filters; diagnostic instruments and equipment includes automated biochemistry analysers, hematology analysers, immunoassay analysers, molecular diagnostic instruments, microbiology instruments and electrolyte analyser; rapid test kit... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2019

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol AVIENCE

Full Company Profile

Financial Performance

In fiscal year 2025, Avience Biomedicals's revenue was 452.36 million, an increase of 88.77% compared to the previous year's 239.64 million. Earnings were 72.91 million, an increase of 238.85%.

Financial Statements